Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
70.70
+1.22 (1.76%)
Sep 15, 2025, 9:59 AM EDT - Market open
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $2.32 billion as of September 15, 2025. Its market cap has increased by 54.91% in one year.
Market Cap
2.32B
Enterprise Value
2.14B
1-Year Change
54.91%
Ranking
Category
Stock Price
$70.70
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $2.32B, an increase of 1,505.65%. That is a compound annual growth rate of 127.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 2.28B | 17.08% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |